[1] Nathanson E,Nunn P, Uplekar M, et al. MDR tuberculosis—critical steps for prevention and control. N Engl J Med,2010,363(11):1050-1058. [2] World Health Organization.WHO report 2011:global tuberculosis control.WHO/HTM/TB/2011.16. Geneva:World Health Organization,2011. [3] World Health Organization.Global tuberculosis control:epidemiology,strategy,financing. Genera: World Health Organization,2009. [4] 王胜芬,赵冰,宋媛媛,等.我国耐药结核病的危险因素——2007年全国结核病耐药基线调查资料分析.中国防痨杂志,2013,35(4):221-226. [5] Glanz K, Rimer BK, Viswanath K. Health behavior and health education:theory,research and practice. 4th ed. San Francisco:Jossey-Bass,2008:406. [6] Green LW, Kreuter MW. Health program planning: an educational and ecological approach.4th ed.New York: McGraw-Hill,2005:87-90. [7] 中国全球基金耐多药结核病项目办公室.第七轮中国全球基金耐多药结核病项目(一期)实施方案.北京:中国全球基金耐多药结核病项目办公室,2008. [8] 于兰,吕青,夏愔愔,等.2010年全国结核病防治核心信息全民知晓率调查分析.中国防痨杂志,2013,35(1):60-64. [9] 李明虎,孙谨芳.耐多药结核病患者治疗管理依从性影响因素分析.中国防痨杂志,2009,31(10):617-618. [10] Jeon CY, Hwang SH, Min JH, et al. Extensively drug-resis-tant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referal hospital. Clin Infect Dis, 2008, 46(1): 42-49. [11] 沈鑫,沈梅,桂晓虹,等.上海市流动人口的结核病耐药状况及相关因素分析.中华结核和呼吸杂志, 2007, 30(6): 407-410. [12] Bhatt G, Vyas S, Trivedil K. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City. Indian J Tuberc, 2012, 59(1):18-27. [13] 姚嵩,方雪晖,陈根旺,等.安徽省流动人口结核病防治干预措施的效果评价.中国防痨杂志,2014,36(4):244-247. [14] 世界卫生组织.耐药结核病规划管理指南(2008年紧急修订版).中国疾病预防控制中心结核病防治临床中心,世界卫生组织结核病培训合作中心,中华医学会结核病学分会,译.北京:中国疾病预防控制中心结核病防治临床中心,2008. [15] Long Q,Smith H,Zhang T,et al. Patient medical costs for tuberculosis treatment and impacr on adherence in Chaia: a systematic review. BMC Public Health,2011,11:393. |